ProPep
AMP-2P
Weight & metabolism

Tirzepatide

Zepbound • Mounjaro

Clinical evidence

A dual-receptor agonist with evidence tied to specific prescription products and patient groups.

Peptide • GIP / GLP-1 receptor agonist

Product & jurisdiction matter

US: Zepbound and Mounjaro are specific prescription products with their own indications. A compound name alone does not establish product approval.

Trinidad & Tobago product registration and supply authorization have not been verified. US status is reference context only.

How it works

Activates both GIP and GLP-1 receptors, pathways involved in metabolic signaling. A dual mechanism does not by itself determine whether a medicine is suitable for a particular person.

What the evidence shows

Zepbound is FDA-approved for long-term weight reduction in specified adults and moderate-to-severe obstructive sleep apnea in adults with obesity, alongside diet and physical activity. Read the label for eligibility and indication details.

What it does not establish

These findings concern the approved product and studied populations. They do not establish the identity, quality or equivalence of research or compounded alternatives.

Safety & unanswered questions

Gastrointestinal adverse effects are common. The label includes a boxed thyroid C-cell tumor warning and severe gastrointestinal and other safety warnings. It does not recommend combining Zepbound with other tirzepatide products or GLP-1 receptor agonists.

A useful question to ask

What distinguishes an approved formulation from a research product with the same name?

Read the sources

  1. Zepbound prescribing information · current label (opens in a new tab)

Educational information, not a treatment recommendation or instructions for use. Research peptides are sold for laboratory research only.

Read the full guide

Research Peptides

Browse our research peptide range, available in retail and wholesale quantities.

See All Products

AMP-2P

$3,000.00$2,500.00per vial

  • Compound: Tirzepatide
  • Content: 30mg per vial
  • Format: Lyophilized powder
  • Purity: 99%
  • Use: For laboratory research use only
  • Notice: Not for human or animal consumption. Not for diagnostic, therapeutic, or clinical use.

Availability: In stock

TitleRangePrice per vial
20% off5 - 9$2,000.00
25% off10 +$1,875.00

Dual GLP Agonist

Peptides are short chains of amino acids, the building blocks of proteins. The research peptides in our range are synthesised to a high purity and supplied as a lyophilised (freeze-dried) powder in a sealed, labelled vial, for use in laboratory and scientific research.

Every product is priced and sold per vial, and each vial's label shows the compound and the amount it contains. Buy single vials at the retail price, or order more and save: quantity discounts are applied automatically in your cart, and wholesale pricing applies from the minimum bulk order quantity shown on each product. Orders are available for collection or delivery.

Product Specifications

  • Compound: Tirzepatide
  • Amount per vial: 30mg
  • Form: Lyophilized powder
  • Purity: 99%
  • Verification: QR code on label for quick access to related documentation (when available)

Handling & Storage

  • For trained personnel handling research materials in an appropriate lab setting.
  • Store in a cool, dry place away from direct light. Follow your lab's SOPs for storage conditions and handling procedures.
  • Use appropriate PPE and standard laboratory safety practices when handling.